L-pipecolic acid is a non-protein amino acid commonly found in plants, animals, and microorganisms. It is a well-known precursor to numerous microbial secondary metabolites and pharmaceuticals, including anticancer agents, immunosuppressants, and several antibiotics. Lysine cyclodeaminase (LCD) catalyzes β-deamination of L-lysine into L-pipecolic acid using β-nicotinamide adenine dinucleotide as a cofactor. Expression of a human homolog of LCD, μ-crystallin, is elevated in prostate cancer patients. To understand the structural features and catalytic mechanisms of LCD, we determined the crystal structures of Streptomyces pristinaespiralis LCD (SpLCD) in (i) a binary complex with NAD + , (ii) a ternary complex with NAD + and L-pipecolic acid, (iii) a ternary complex with NAD + and L-proline, and (iv) a ternary complex with NAD + and L-2,4-diamino butyric acid. The overall structure of SpLCD was similar to that of ornithine cyclodeaminase from Pseudomonas putida. In addition, SpLCD recognized L-lysine, L-ornithine, and L-2,4-diamino butyric acid despite differences in the active site, including differences in hydrogen bonding by Asp236, which corresponds with Asp228 from Pseudomonas putida ornithine cyclodeaminase. The substrate binding pocket of SpLCD allowed substrates smaller than lysine to bind, thus enabling binding to ornithine and L-2,4-diamino butyric acid. Our structural and biochemical data facilitate a detailed understanding of substrate and product recognition, thus providing evidence for a reaction mechanism for SpLCD. The proposed mechanism is unusual in that NAD + is initially converted into NADH and then reverted back into NAD + at a late stage of the reaction.
INTRODUCTION
L-Pipecolic acid (L-Pip), also known as L-homoproline and piperidine-2-carboxylic acid, is a well-known precursor of various secondary metabolites in plants, animals, and microorganisms (Durzan, 1983; Zacharius et al., 1954) . Lysine cyclodeaminase (LCD) catalyzes β-deamination of L-lysine into L-Pip using β-nicotinamide adenine dinucleotide as a cofactor. In humans, L-Pip is synthesized in the brain and accumulates in the physiological fluids of patients with peroxisomal disorders, such as hyperpipecolic academia, Zellweger syndrome, and infantile Refsum disease (Mihalik et al., Expression of a human LCD homolog, μ-crystallin, is elevated in prostate cancer patients (Malinowska et al., 2009) . In plants, L-Pip acts as an osmoprotectant, inducer of flowering, indicator of abnormal amino acid metabolism, and has a critical role in plant immunity (Fujioka and Sakurai, 1992; Moulin et al., 2006; Návarová et al., 2012; Pálfi and Dézsi, 1968) . In bacteria, L-Pip is synthesized during L-lysine metabolism and acts as an osmoprotectant, thus enabling bacteria to grow in hyperosmotic environments (Gouesbet et al., 1994; Neshich et al., 2013) .
L-Pip is a useful precursor of several pharmaceuticals, including the immunosuppressant FK506, rapamycin, the anticancer agent VX710, and the antibiotics demethoxyrapamycin, sandramycin, and meridamycin (Bis et al., 2015; Boger et al., 1996; Gatto et al., 2006; Germann et al., 1997; Kadouri-Puchot and Comesse, 2005; Watanabe et al., 2005) . As the importance and utility of L-Pip derivatives have become increasingly well-known, chemists have been developing different methods by which to synthesize L-Pip (Couty, 1999; Eichhorn et al., 1997; Lemire and Charette, 2010; Wilkinson et al., 2000) . In particular, enzymatic production of L-Pip using the L-lysine metabolic pathway has been extensively investigated (Broquist, 1991; Byun et al., 2015; Fujii et al., 2002; Garcia et al., 2016; Gupta and Spenser, 1969; Miller and Rodwell, 1971; Tani et al., 2015; Ying et al., 2015; 2017a) , because the precursor L-lysine is abundant in nature and enzymatic synthesis of L-Pip yields a product with better chiral purity than chemical synthesis. Two metabolic pathways have previously been investigated for use in the enzymatic synthesis of L-Pip (Broquist, 1991; Gupta and Spenser, 1969; Miller and Rodwell, 1971) . However, both of these metabolic routes require two or more enzymes and involve several steps to produce L-Pip from L-lysine, which results in problematic byproducts and high purification costs (He, 2006) . By contrast, it has been shown that LCD can directly convert L-lysine into L-Pip in one step using NAD + as a cofactor (Gatto et al., 2006; Tsotsou and Barbirato, 2007) , which is more efficient than other methods used for L-Pip biosynthesis. Recently, conditions for L-Pip biosynthesis using LCD from Streptomyces pristinaespiralis (SpLCD) were optimized to increase catalytic efficiency (Byun et al., 2015; Tsotsou and Barbirato, 2007; Ying et al., 2015; 2017a) . In addition, the crystal structures of SpLCD in complex with L-lysine and L-Pip have been determined and their modes of binding described (Ying et al., 2017b) . Interestingly, SpLCD has a range of substrates with carbon lengths ranging from 4-6 carbons. However, it is currently unknown how SpLCD recognizes and acts on this diverse range of substrates, including how L-lysine and L-ornithine are converted into L-Pip and L-Proline (L-Pro), respectively. L-lysine has been demonstrated to be the best substrate for SpLCD, of all the known substrates such as L-2,4-diamino butyric acid (L-DABA), Lornithine, and L-lysine, which have four, five, and six carbon chains, respectively (Byun et al., 2015) .
The crystal structure and binding of ornithine cyclodeaminase (OCD) in complex with ornithine have been described (Goodman et al., 2004) . Based on OCD X-ray crystallographic and mass spectroscopic data, a reaction mechanism has been proposed for OCD (Gatto et al., 2006; Goodman et al., 2004) . The proposed mechanism is unusual in that NAD + is initially converted into NADH and then reverted back into NAD + at a late stage, where the pyridine nucleotide acts as a cosubstrate during most enzymatic reactions that utilize NAD(P) + and NAD(P)H (Gatto et al., 2006) . Similar use of NAD(P) + as a catalytic cofactor has been proposed for other enzymes, including UDP-galactose 4-epimerase (Frey, 1996) , S-adenosylhomocysteine hydrolase (Hu et al., 2001) , and myo-inositol-1-phosphate synthase (Gatto et al., 2006; Jin and Geiger, 2003) . Mechanisms similar to those utilized by OCD have been proposed for LCD. However, the LCD substrate L-lysine contains one carbon more than ornithine. Therefore, it would be of interest to determine how LCD and OCD active sites recognize their substrates and how their reaction mechanisms differ.
Because of the unusual reaction mechanism suggested for LCD and the importance of the reaction product L-Pip, we undertook a crystallographic study of LCD derived from S. pristinaespiralis. This provided a structural basis for determin- By comparing the binding pockets of LCD and OCD, we found the hydrogen bonding residues, including Asp236, allow recognition of lysine as a substrate. Our structural and biochemical data facilitate a detailed understanding of substrate and product recognition by SpLCD, thus informing a proposal for the structure-based reaction mechanism for SpLCD.
MATERIALS AND METHODS
Cloning and protein preparation L-lysine cyclodeaminase from S. pristinaespiralis (amino acids 1-355) was cloned into the pET21b (+) expression vector. This construct encoded an N-terminal His 6 tag and the SpLCD gene under the control of the T7 promoter. The SpLCD protein was produced in Escherichia coli strain BL21 (DE3) by inducing expression with 0.5 mM isopropyl-β-D-1-thiogalactopyranoside and incubating at 25℃ for 16 h. To lyse the cells, the cells were passed through a microfluidizer in lysis buffer A (20 mM Tris-HCl, pH 8.0, and 200 mM NaCl) containing 1 mM phenylmethylsulfonyl fluoride and 5% (w/v) glycerol. The lysed cells were centrifuged at 4,611 g (Vision V506CA rotor) for 30 min at 277 K to pellet cellular debris. The resulting supernatant was run through Ni-sepharose affinity resin (GE Healthcare). Proteins were eluted with buffer A containing 100-300 mM imidazole, further purified by size exclusion chromatography (HiLoad 16/600 Superdex 200 prep grade, GE Healthcare), and then concentrated to 30 mg/ml by ultrafiltration. The extinction coefficient of SpLCD was calculated using ProtParam (http://web.expasy.org/protparam).
Crystallization, determination of structure, and refinement Crystals of SpLCD in complex with NAD + were grown at 298 K using the sitting drop method Briefly, 1 μl of a 10 mg/ml solution of SpLCD in buffer A was mixed with 1 μl of reser-voir solution (100 mM CAPSO buffer at pH 9.6, 0.2 M Li 2 SO 4 , 0.9 M Na-K tartrate, and 2% polyethylene glycol 3350) in the presence of 10 mM NAD . The structures were solved using the molecular replacement method using the Archaeoglobus fulgidus alanine dehydrogenase model, Protein Data Bank (PDB) entry 1OMO, as a probe (Gallagher et al., 2004) . 
, where I(h) is the intensity of reflection h, Σ h is the sum over all reflections, and Σ i is the sum over i measurements of reflection h. c R = Σ hkl | … |Fobs| -|Fcalc| | / Σhkl |Fobs|, where R free was calculated for a randomly chosen 5% of reflections, which were not used for structure refinement and R work was calculated for the remaining.
Cross-rotational and then translational searches were performed using the PHASER program (McCoy et al., 2007 ).
Subsequent manual model building was performed using the COOT program (Emsley and Cowtan, 2004 ) and restrained refinement was carried out using the PHENIX program (Adams et al., 2002) . Several rounds of model building, simulated annealing, positional refinement, and individual Bfactor refinement were performed using the COOT and PHENIX programs. Table 1 
Analytical gel filtration
Purified SpLCD was subjected to analytical gel filtration chromatography using a Superdex 200 (10/300 GL) column with buffer A flowing at a constant rate of 0.5 ml/min (Choi et al., 2016) . The standard curve was created using molecular weight markers (Sigma). The Stokes radii of β-amylase, alcohol dehydrogenase, carbonic anhydrase, and cytochrome C were calculated from the crystal structures of each protein (PDB entries 1FA2, 2HCY, 1V9E, and 1HRC, respectively) using the HYDROPRO program (Garcia De La Torre et al., 2000) .
Alignment of sequences
The sequence of S. pristinaespiralis LCD was compared to the sequences of other LCDs and OCDs. The UniProtKB/ Swiss-Prot accession numbers of the sequences used were D9UBW0 (SpLCD), Q8RR22 (SvLCD) A0A0A0NQJ4 (SrLCD), E9KTB3 (SkLCD), U5VYY1 (AfLCD), Q9R468 (AtOCD), A0A179QU84 (PpOCD), A9WVR4 (BsOCD), C4IUX0 (BaOCD), and A0A0T7GIJ3 (NgOCD). Sequences were aligned using ClustalX (Thompson et al., 1997) , and secondary structure elements were assigned using PyMOL (PyMOL Molecular Graphics System, http://www.pymol.org). 
RESULTS AND DISCUSSION
Determination of the crystal structure of S. pristinaespiralis LCD Crystal structures of SpLCD were determined using the molecular replacement method based on the A. fulgidus alanine dehydrogenase model (PDB entry 1OMO) (Gallagher et al., 2004) (Figs. 1A and 1B) . Table  1 ). The last eleven disordered residues ( 345 PLPLPLAAPAH 355 ) of the C-termini are not shown for these structures. These residues are not conserved among LCDs, suggesting they are not critical for enzymatic functions. The refined model of Fig. 2 . Sequence alignment of SpLCD with LCDs and OCDs from other species. Multi-alignment of SpLCD (UniProtKB/Swiss-Prot accession numberD9UBW0) against LCD from Streptomyces virginiae(UniProtKB/Swiss-Prot accession numberQ8RR22), Streptomyces hygroscopicus(UniProtKB/Swiss-Prot accession numberA0A0A0NQJ4), Streptomyceskanamyceticus (UniProtKB/Swiss-Prot accession numberE9KTB3), Actinoplanes friuliensis(UniProtKB/Swiss-Prot accession numberU5VYY1), Agrobacterium tumefaciens (UniProtKB/SwissProt accession numberQ9R468), Pseudomonas putida(UniProtKB/Swiss-Prot accession numberA0A179QU84), Brucella suis biovar 1(UniProtKB/Swiss-Prot accession numberA9WVR4), Brucella abortus biovar 1 (UniProtKB/Swiss-Prot accession numberC4IUX0), and Neorhizobium galegae by officinallis (UniProtKB/Swiss-Prot accession number A0A0T7GIJ3). Secondary structural elements were assigned using PyMOL and every twentieth residue is marked with a black dot. Strictly (100%) and semi-conserved residues (80%) are highlighted in green and light blue, respectively. Cylinders and arrows above the sequences denote α-helices and β-strands, respectively. Black, magenta, and cyan triangles below the LCD sequences denote L-pipecolic acid, L-proline, and L-DABA, respectively. Black boxes indicate residues interacting with water molecules when LCD or OCD bound its ligands and blue boxes denote residues interact with water molecules when LCD bound its cofactor; NAD + . Red and blue diamonds represent residues in the structures of SpLCD and Pseudomonas putida ornithine cyclodeaminase (PpOCD) that coordinate with NAD + and NADH, respectively. Residues interacting with Lornithine in OCD are shown in a pink triangle. SpLCD/NAD + includes residues 1-344 in an asymmetric unit with 1,229 water molecules. Ramachandran plot analysis of the refined SpLCD/NAD + model showed that 96.8, 2.9, and 0.3% of the non-glycine residues were in the most favored, allowed, and disallowed regions, respectively (Table 1 ). The crystal structure of SpLCD/NAD + primarily consisted of fourteen strands and fifteen helices (Fig. 1A) . The structure of SpLCD was comprised of a dimer of identical subunits, which corroborates with a previous study on PpOCD (Goodman et al., 2004) (Fig. 1B) . Each subunit consisted of two domains that function in substrate binding, oligomerization, and cofactor binding (Fig. 1B) . Single dinucleotide bonds in each subunit were formed via a Rossmann fold (Fig.  1B) . The overall molecular dimension of the LCD dimer was 50 × 80 × 45 Å with the two longest dimensions oriented in the plane presented in Fig. 1B .
Overall structure and structural comparisons
The overall structure of SpLCD resembled PpOCD, alanine dehydrogenase (AlaDH), and human μ-crystallin (CRYM). A search for structural similarity with SpLCD using the DALI server (Holm and Rosenstrom, 2010) identified crystal structures of OCD (PDB entry 1U7H) (Goodman et al., 2004) , AlaDH (PDB entry 1OMO) (Gallagher et al., 2004) , and CRYM (PDB entry 2I99) (Cheng et al., 2007) . When the structure of SpLCD/NAD + was overlaid with structures of OCD from Pseudomonas putida, AlaDH from A. fulgidus, and CRYM from humans, the r.m.s. deviations were 1.9 Å, 2.0 Å, and 2.2 Å for the 335, 313, and 306 Cα atoms, respectively. The PpOCD structure had the highest Z-score of 43.8 when superimposed with SpLCD despite differences in the NAD + binding site. To analyze the oligomeric state of SpLCD in solution, analytical gel filtration was performed using a Superdex 200 (10/300 GL) column. The Stokes radius of SpLCD was estimated to be 3.91 nm, which is very similar to the Stokes radius calculated for the SpLCD dimer (3.43 nm) (Fig. 1C) (Figs. 2 and 3) . However, there were some differences in the residues that interact with cofactors and substrates (Figs. 2 and 3 ). In the SpLCD/NAD + complex, the main chain of Ala 235 formed a hydrogen bond with the O3 atom of NAD + (3.07 Å), while the side chain of Lys 232 in PpOCD was involved in hydrogen bonding with the O3 atom of NAD + (2.95 Å) (Fig. 3) . The Lys 232 side chain of PpOCD interacted with the O2 atom of NAD + (2.75 Å) (Fig. 3) (Fig. 2) . The main chain of Pro 83 formed a hydrogen bond with a water molecule (3.08 Å) that interacted with the O7 atom of NAD + (2.68 Å) and the side chain of Ser 210 (2.77 Å). Finally, the main chain of Val 218 interacted with the N4 atom of NAD + (2.84 Å) through a water molecule (2.70 Å) (Fig. 2) . These direct and indirect hydrogen bonds between NAD + and SpLCD residues create a stable SpLCD/NAD + complex for catalysis.
Structural insights into ligand recognition by SpLCD
To obtain information on the binding between SpLCD and Llysine, we attempted to co-crystallize SpLCD with L-lysine. However, we instead obtained the electron-density map of L-Pip, the catalytic product of SpLCD (Fig. 4A ), suggesting A B C the reaction occurred prior to crystallization. Similarly, the electron density map of L-Pro was obtained when SpLCD was co-crystallized with L-ornithine (Fig. 4B) . When we attempted to co-crystallize SpLCD with L-DABA, L-DABA was unable to be transformed in ring form. Instead, the electron density associated with L-DABA was observed (Fig. 4C) . These results suggest that SpLCD has catalytic activity for Llysine and L-ornithine and L-DABA is too short for ring formation. This is consistent with previous studies demonstrating SpLCD is able to perform catalysis on a range of substrates of varying carbon lengths (Byun et al., 2015; Tsotsou and Barbirato, 2007) . Structural comparisons of SpLCD in complex with L-Pip, L-Pro, and L-DABA revealed that binding of the carboxyl group attached to the C2 carbon was similar for each substrate (Fig. 4) , suggesting this binding significantly contributes to substrate recognition. , and Thr 302 were directly involved in hydrogen bonding with L-Pro (2.67 Å, 2.74 Å, and 3.20 Å, respectively), while the side chain of Glu 63 indirectly interacted with the N1 atom of L-Pro via one water molecule in a manner similar to the SpLCD/L-Pip structure (Fig. 4B) .
To interact with L-DABA, additional side chains were required to stabilize L-DABA in the active site. The side chains of Glu (Fig. 4C) . The carbonyl oxygen of Ala 235 (3.20 Å) and O2
atom of NAD + (3.25 Å) formed hydrogen bonds with the N2 atom of L-DABA (Fig. 4C) (Fig. 4C) . To examine what makes L-Lys the optimal substrate for SpLCD, a composite model was created by incorporating the L-ornithine molecule from the PpOCD/L-ornithine structure into our SpLCD structure (Fig. 5A) , and NAD + in SpLCD created a space that accommodated L-lysine, which has one carbon more than L-ornithine.
Proposed reaction mechanism of SpLCD
The reaction mechanism of LCD has previously been extensively studied using OCD and two distinct catalytic mechanisms have been proposed (Graupner and White, 2001 ). In one proposal, the reaction proceeds through direct attack, where a water molecule becomes an imino intermediate (Graupner and White, 2001) . The other proposal suggested that the δ-amino group directly attacks the C2 position of Lornithine without prior hydrolysis with the α-amino group subsequently leaving the intermediate molecule (Goodman et al., 2004) . Despite the presence of two amino groups, α and δ, in L-ornithine, an elegant study using 15 N-radiolabled ornithine determined that the α-amino group at the C2 position is the amino group involved in cyclization (Graupner and White, 2001) . Of the two proposals, the latter is plausible based on structural studies of PpOCD and SpLCD (Goodman et al., 2004; Ying et al., 2017b) . In PpOCD, one water molecule resides near the C2 position of L-ornithine and binds the side chain of Glu 56 and the α-amino group. However, the position of the water is not suitable for directly attacking the C2 carbon (Goodman et al., 2004) .
Despite extensive studies on the mechanism of catalysis of OCD, no structures of OCD in complex with its product, LPro, have been reported. In this study, we solved the crystal structure of SpLCD in complex with several reaction products, including L-Pro and L-Pip, enabling us to confirm the previously proposed mechanism of catalysis. The LCD substrate Llysine contains one carbon more than the OCD substrate Lornithine. Therefore, the reaction mechanism may be similar. By elucidating the structure of SpLCD and comparing it to the PpOCD structure, we developed the following mechanism. When L-lysine binds to the active site, the hydride ion is transferred to the NAD + cofactor, resulting in an imino substitution (Fig. 5B ). This process is facilitated by a neighboring general base. In OCD, Asp 228 has been suggested to be this general base because it is directly coordinated with an α-amino group (Goodman et al., 2004 , is located far from the α-amino group (Fig. 5A) . Rather, a water molecule forms a hydrogen bond with the α-amino group and the side chain of Glu 63 (Fig. 5A) , suggesting that the water molecule may serve as general base by donating a proton to Glu
63
. The next step is direct attack of the δ-amino group to the C2 position of the intermediate molecule in order to form the six-membered ring of L-Pip (Fig. 5B) . This mechanism could be beneficial for producing L-Pip, which is a useful precursor in pharmaceutical synthesis, because it does not require NADH molecules to be continually supplied during synthesis.
